4CPS-055 Effectiveness and safety of ribociclib in the first line of luminal metastatic breast cancer

MJ Canalejo Fuentes; AB Fernández Román; B Candel García; J Letéllez Fernández; M García Gil

doi:10.1136/ejhpharm-2023-eahp.384

Article info

PDF

Late breaking abstracts

4CPS-055 Effectiveness and safety of ribociclib in the first line of luminal metastatic breast cancer

Free

Authors

MJ Canalejo Fuentes Fuenlabrada University Hospital, Pharmacy Unit, Fuenlabrada, Spain PubMed articles Google scholar articles
AB Fernández Román Fuenlabrada University Hospital, Pharmacy Unit, Fuenlabrada, Spain PubMed articles Google scholar articles
B Candel García Fuenlabrada University Hospital, Pharmacy Unit, Fuenlabrada, Spain PubMed articles Google scholar articles
J Letéllez Fernández Fuenlabrada University Hospital, Pharmacy Unit, Fuenlabrada, Spain PubMed articles Google scholar articles
M García Gil Fuenlabrada University Hospital, Pharmacy Unit, Fuenlabrada, Spain PubMed articles Google scholar articles

Citation

Canalejo Fuentes M, Fernández Román A, Candel García B, et al

4CPS-055 Effectiveness and safety of ribociclib in the first line of luminal metastatic breast cancer

European Journal of Hospital Pharmacy 2023;30:A185.

Publication history

First published May 2, 2023.

Online issue publication

May 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password